Print this page
Individual Patient Expanded Access for Nonconforming BMS CAR T Cell Therapy
The objective of this trial is to treat patient Patient ENR-007072 with ABECMA drug product Lot R2R1-WH174J
Protocol Number:
012323
Phase:
N/A
Applicable Disease Sites:
Multiple Myeloma
Scope:
Local
Participating Institutions:
- Rutgers Cancer Institute of New Jersey
- Principal Investigator
- Amer Assal MD
- Principal Investigator
For further information about clinical trials, please contact us at 732-235-7356.